DRUG CONTROLLER OF UTRAKHAND DISCLOSES TRUTH

New Delhi May 17, 2016,
Drug Controller of Utrakhand had issued warning notice dated May 06 2016 to all manufacturers to come personally with original approval copy issued up till now. By hook or crook all manufacturers have to reach to drug controller office on or before May 15, 2016. This warning notice is applicable to all loan licenses as well.
This warning notice itself confirms that drug controller office has lost the data available with them or they never bothered to maintain approval data.

Firstly they issued approval of fixed dose combinations and others and now it is confirm that they do not have copy of new drug approval issued to the manufacturers.
They are so money eyed that they forget to keep record of new drug and FDC approval and at the end of the day they force industry people to come to the court rather than doing business.
In friendly atmosphere they issue approval and when media comes in between then they pose themselves dry honest controller and try to prove manufacturers all time villain.
Tajbar Singh Ji, Please follow total quality management and six sigma quality tool so that you can save life of innocent Indians. You are controller of Drug, it saves life or kills life. Your approach is casual and you are not fit for the controller position, hence you should resign then and there.
Email:medicarechief@gmail.com

Related Posts

NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert